1 INTRODUCTION

    1.1 Study Objectives
    1.2 Market Definition

        1.2.1 Inclusions & Exclusions
        1.2.2 Market Segmentation
        1.2.3 Years Considered
        1.2.4 Currency Considered

    1.3 Limitations
    1.4 Stakeholders
    1.5 Summary of Changes

2 MARKET OVERVIEW

    2.1 Introduction
    2.2 Market Dynamics

        2.2.1 Drivers

            2.2.1.1 Rising incidence of chronic diseases
            2.2.1.2 Favorable reimbursements in certain  countries
            2.2.1.3 Growing adoption of self-administration
            2.2.1.4 Decreasing prices of insulin formulations

        2.2.2 Restraints

            2.2.2.1 Alternative methods of drug delivery
            2.2.2.2 Poor reimbursement scenario in  emerging markets
            2.2.2.3 Needle anxiety

        2.2.3 Opportunities

            2.2.3.1 Growing preference for biosimilar drugs
            2.2.3.2 Emerging economies to offer highgrowth potential
            2.2.3.3 Rising healthcare expenditure on diabetes
            2.2.3.4 Implementation of regulations for safety  pen needles

        2.2.4 Challenges

            2.2.4.1 ReUse of pen needles
            2.2.4.2 MisUse of injection pens

    2.3 Industry Trends

        2.3.1 Growing Preference for Safety-Engineered Pen  Needles
        2.3.2 Rising Adoption of Shorter and Ultra-Thin Needles

    2.4 Reimbursement Scenario
    2.5 Value Chain Analysis
    2.6 Ecosystem Analysis
    2.7 Porter’s Five Forces Analysis

        2.7.1 Intensity of Competitive Rivalry
        2.7.2 Bargaining Power of Suppliers
        2.7.3 Bargaining Power of Buyers
        2.7.4 Threat of Substitutes
        2.7.5 Threat of New Entrants

    2.8 Supply Chain Analysis
    2.9 Trade Analysis

        2.9.1 Trade Analysis of Needles, Catheters, and Cannulae  Used in
              Medical, Surgical, Dental, or Veterinary  Sciences (HS Code
              901839)
        2.9.2 Export Data (HS Code 901839), 2019–2023
        2.9.3 Import Data (HS Code 901839), 2019–2023

    2.10 Patent Analysis

        2.10.1 Patent Publication Trends for Pen Needles
        2.10.2 Insights: Jurisdiction and Top Applicant Analysis

    2.11 Technology Analysis

        2.11.1 Key Technologies

            2.11.1.1 Fluid flow enhancement technology
            2.11.1.2 Ultra-thin needle technology

        2.11.2 Complementary Technologies

            2.11.2.1 Microfabricated needles
            2.11.2.2 AI in pen injectors

        2.11.3 Adjacent Technologies

            2.11.3.1 Autoinjectors

    2.12 Key Conferences & Events, 2025–2026
    2.13 Adjacent Market Analysis

        2.13.1 Autoinjectors Market
        2.13.2 Insulin Delivery Devices Market
        2.13.3 Injection Pens Market
        2.13.4 Needles Market

    2.14 Impact of AI/Gen AI on Pen Needles Market
    2.15 Trends/Disruptions Impacting Customers’ Business
    2.16 Unmet Needs Analysis
    2.17 Investment & Funding Scenario

3 COMPETITIVE LANDSCAPE

    3.1 Introduction
    3.2 Key Player Strategies/Right to Win

        3.2.1 Overview of Strategies Adopted By Key Players in  Pen Needles
              Market

    3.3 Revenue Analysis, 2019–2023
    3.4 Market Share Analysis, 2023
    3.5 Company Evaluation Matrix: Startups/SMEs, 2023

        3.5.1 Progressive Companies
        3.5.2 Responsive Companies
        3.5.3 Dynamic Companies
        3.5.4 Starting Blocks
        3.5.5 Competitive Benchmarking

            3.5.5.1 Detailed list of key startups/SMEs
            3.5.5.2 Competitive benchmarking of key  startups/SMEs

    3.6 Company Valuation & Financial Metrics
    3.7 Competitive Scenario

        3.7.1 Product Launches & Approvals
        3.7.2 Deals
        3.7.3 Expansions

    3.8 Brand/Product Comparison

4 COMPANY PROFILES

    4.1 GLUCORX LIMITED

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 SIMPLE DIAGNOSTICS

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 WELLION

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 LINKS MEDICAL PRODUCTS INC.

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 MHC MEDICAL PRODUCTS, LLC

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 ADVACARE PHARMA

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 MEDEXCEL

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments

    4.8 PROMISEMED MEDICAL DEVICES, INC.

        4.8.1 Business overview
        4.8.2 Products/Solutions/Services offered
        4.8.3 Recent developments

    4.9 FEEL TECH

        4.9.1 Business overview
        4.9.2 Products/Solutions/Services offered
        4.9.3 Recent developments

    4.10 MONTMED

        4.10.1 Business overview
        4.10.2 Products/Solutions/Services offered
        4.10.3 Recent developments